News

Generics claim 78% of US market; prescriptions dispensed were up slightly, but doctor visits declined in 2010

Cost dominates the payer and physician perspective, manufacturers look to outcomes, while patients see little value in outcomes

Electronic health-record systems (EHRs) are bringing needed drug information to the point of care for prescribers

Survey of life sciences sales organizations finds mobile computing is advancing rapidly

Rigorous, peer-reviewed analysis of hypertension patients is “an absolute baseline” for justifying compliance packaging, says MWV

AmerisourceBergen CEO has had a 37-year career in healthcare distribution

Product innovations, and excellence in trade relations practices are honored

Contract win could prove to be a turnaround for still-controversial CVS-Caremark merger; will medication adherence programs make a difference?

Vermont’s amended program directly affects how samples are distributed to healthcare providers; ambiguities remain in who and what need to be reported

Coincidentally, federally sponsored study sees a link between high-speed Internet access and online drug sales of narcotic medicines

New edition updates regulatory developments, economics of transportation modes and trends in international product movement

Sales-force automation vendor races to pole position for sales teams deploying the iPad 2

Bill brings state into national efforts at prescription drug monitoring programs (PDMPs), and adds requirements to pharmacists and distributors

Emphasis is on operating a single instance for multiple clients

HCPC symposium presentation hints at “science based” data from retrospective patient studies

Annual competition highlights the value of unit-dose packaging in medication adherence

Chains now handle 54.4% of prescriptions; mail order flat at 6.6%

PDR Network plans to incorporate sponsored services like co-pay cards or dosage calculators in the information available to prescribers via EHR interfaces

IMS Health, SDI and Wolters Kluwer make a First Amendment argument for access to physicians’ prescribing information

Generics claim 78% of market; prescriptions dispensed up slightly, but doctor visits decline

Caseload reinforces concerns over illegal trade and distribution of pharmaceuticals

UDP proponents have solid data that demonstrate that this form of packaging maintains better compliance with treatment regimens

Nearly 200 drugs now carry requirements for a risk management program, as FDA evaluates the initial follow-up reporting from manufacturers